Liphorus Pharmaceuticals
Liphorus Pharmaceuticals develops therapeutic antibodies that can be used to treat hypercholesterolemia.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Liphorus Pharmaceuticals Information
Geographic Data
Address: 1010 Sherbrooke Street West
City: Montreal
State: quebec
Zip: H3A 2R7
Country: CA
Financial Info
Stage:
series a
Raised Last:
$6M
Raised Total:$6M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Liphorus Pharmaceuticals develops small compounds that target PCSK9 to treat hypercholesterolemia. Along with this initial round of funding, the company has a research agreement with the IRCM that will enable it to create and validate compounds that target PCSK9.
Contact Phone:
+15145646474
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2014 | Series A | 2 | $6.4M |
Sanderling Ventures Univalor Sanderling Ventures Univalor |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
